Abstract
Repulsive guidance molecules (RGMs) are a group of glycosylphosphatidylinositol (GPI)-linked cellmembrane- associated proteins recently described. RGM family members play a diverse role in axonal guidance during embryo development, neuronal cell adhesion and regulation of systemic iron metabolism. Another important role of the RGM family, discovered recently, is that they act as co-receptors of bone morphogenetic proteins (BMPs), a group of proteins that are involved in bone development and the differentiation and progression of cancer. This indicates the potential impact of RGMs on cancer. The current review discusses the present knowledge on RGMs, their roles in BMP signalling and their potential implication in development and progression of cancer, particularly in the BMPs related bone metastasis.
Keywords: Repulsive guidance molecules (RGM), Neogenin, BMP signalling pathway, Smad, Cancer
Current Signal Transduction Therapy
Title:Repulsive Guidance Molecules (RGMs) and Their Potential Implication in Cancer as Co-receptor of BMPs
Volume: 7 Issue: 2
Author(s): Jin Li, Lin Ye and Wen G. Jiang
Affiliation:
Keywords: Repulsive guidance molecules (RGM), Neogenin, BMP signalling pathway, Smad, Cancer
Abstract: Repulsive guidance molecules (RGMs) are a group of glycosylphosphatidylinositol (GPI)-linked cellmembrane- associated proteins recently described. RGM family members play a diverse role in axonal guidance during embryo development, neuronal cell adhesion and regulation of systemic iron metabolism. Another important role of the RGM family, discovered recently, is that they act as co-receptors of bone morphogenetic proteins (BMPs), a group of proteins that are involved in bone development and the differentiation and progression of cancer. This indicates the potential impact of RGMs on cancer. The current review discusses the present knowledge on RGMs, their roles in BMP signalling and their potential implication in development and progression of cancer, particularly in the BMPs related bone metastasis.
Export Options
About this article
Cite this article as:
Li Jin, Ye Lin and G. Jiang Wen, Repulsive Guidance Molecules (RGMs) and Their Potential Implication in Cancer as Co-receptor of BMPs, Current Signal Transduction Therapy 2012; 7 (2) . https://dx.doi.org/10.2174/157436212800376690
DOI https://dx.doi.org/10.2174/157436212800376690 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
MicroRNAs: Novel Diagnostic and Prognostic Biomarkers in Atherosclerosis
Current Topics in Medicinal Chemistry Relationship Between Cigarette Smoking and Other Coronary Risk Factors in Atherosclerosis: Risk of Cardiovascular Disease and Preventive Measures
Current Pharmaceutical Design Conformations and Assembly of Amyloid Oligomers by Electrospray Ionisation - Ion Mobility Spectrometry - Mass Spectrometry
Current Analytical Chemistry Imaging and Laboratory Biomarkers in Cardiovascular Disease
Current Pharmaceutical Design Metabolomics and the Diagnosis of Human Diseases -A Guide to the Markers and Pathophysiological Pathways Affected
Current Medicinal Chemistry Can the Electrophysiological Action of Rosiglitazone Explain its Cardiac Side Effects?
Current Medicinal Chemistry mTOR in Growth and Protection of Hypertrophying Myocardium
Cardiovascular & Hematological Agents in Medicinal Chemistry The Role of Negative Costimulators During Parasitic Infections
Endocrine, Metabolic & Immune Disorders - Drug Targets Exosomal MiR-29a in Cardiomyocytes Induced by Angiotensin II Regulates Cardiac Microvascular Endothelial Cell Proliferation, Migration and Angiogenesis by Targeting VEGFA
Current Gene Therapy Pharmacological and Non Pharmacological Strategies in the Management of Coronary Artery Disease and Chronic Kidney Disease
Current Cardiology Reviews L-Arginine Availability as a Pathological Mechanism in Essential Hypertension, Chronic Renal and Heart Failure
Vascular Disease Prevention (Discontinued) Cardiovascular Magnetic Resonance for Evaluation of Heart Involvement in ANCA-Associated Vasculitis. A Luxury or a Valuable Diagnostic Tool?
Inflammation & Allergy - Drug Targets (Discontinued) Alteration of the Beta-Adrenergic Signaling Pathway in Human Heart Failure
Current Pharmaceutical Biotechnology Therapeutic Targeting of Endothelial Dysfunction in Chronic Diabetic Complications
Recent Patents on Cardiovascular Drug Discovery Mechanical Circulatory Support of the Critically Ill Child Awaiting Heart Transplantation
Current Cardiology Reviews Echocardiographic Hemodynamic Monitoring in the Critically Ill Patient
Current Cardiology Reviews Recent Advances in Endocrine Metabolic Immune Disorders Drug Targeting: An Editorial Overview
Endocrine, Metabolic & Immune Disorders - Drug Targets Context-Dependency of Relations Between Cardiovascular Phenotypes and Genes Involved in Sodium Homeostasis: Findings from the European Project on Genes in Hypertension
Current Hypertension Reviews Streptozotocin-Induced Diabetes Mellitus in Neonatal Rats: An Insight into its Applications to Induce Diabetic Complications
Current Diabetes Reviews Cytoprotection by Natural and Synthetic Polyphenols in the Heart: Novel Mechanisms and Perspectives
Current Pharmaceutical Design